Search results

Filters
Close
ADDED DATE
Added date
AUTHOR Please select
TOPICS Please select
WATCH / LISTEN / READ TIME
USC Discussion: Hemodynamics in Cardiogenic Shock
Author(s): Alexander G Truesdell , Jaime A Hernandez-Montfort , Varinder Kaur Randhawa Added: 2 years ago
In this in-depth discussion lead by Dr Alexander Truesdell (Virginia Heart/Inova Heart & Vascular Institute, US), contributors of Cardiogenic Shock Special Focus Collection, Dr Varinder K Randhawa (Cleveland Clinic, US) and Dr Jaime Hernandez-Montfort (Cleveland Clinic Florida, US) discuss the most prevalent questions on hemodynamic-based assessment and management of cardiogenic shock: What is… View more

Heart Failure

MI/ACS
Author(s): Ajit Yoganathan , Fotis Sotiropoulos Added: 3 years ago
Background Since the first successful implantation of a prosthetic heart valve four decades ago, over 50 different designs have been developed including both mechanical and bioprosthetic valves. Today, with over 200,000 implants worldwide each year, the most widely implanted design is the mechanical bileaflet prosthesis. Several other mechanical valves are currently available and many of them… View more

Vascular Disease and Surgery
Author(s): Saumil R Shah , Sergio Waxman , William H Gaasch Added: 3 years ago
Pulmonary venous hypertension and congestion that occurs with left ventricular (LV) failure is generally not seen in the presence of a large atrial septal defect (ASD). As long as right ventricular (RV) function and distensibility are not impaired, the ASD provides an alternate pathway for atrial emptying, thus preventing or attenuating elevated LV filling pressures. When RV dysfunction develops… View more

Heart Failure

Prevention & Chronic Conditions
ACC 22: Results from the POISE-3 Trial
Author(s): Maura Marcucci Added: 2 years ago
In this short interview from our coverage of the ACC.22 late-breaking trials, Dr Maura Marcucci (McMaster University, ON, CA) discusses a sub-study of the POISE-3 trial, which sought to evaluate the effects of a perioperative hypotension-avoidance strategy, compared to a hypertension-avoidance strategy in patients undergoing non-cardiac surgery (NCT03505723). Discussion Points: Study… View more

Vascular Disease and Surgery
Job title: Director
Dr Dan Burkhoff is currently the Director of Heart Failure, Hemodynamics and MCS Research at Cardiovascular Research Foundation, New York, US.Dr Burkhoff's interest include cardiovascular modeling and ventricular mechanics, cardiovascular monitoring, heart failure, device and pharmacologic treatments for heart failure, including left ventricular assist devices.He is also author of Harvi, an… View more
Job title: Head of Hemodynamics and Interventional Cardiology
Prof Jose M de la Torreis an interventional cardiologist and Head of the Hemodynamics and Interventional Department of the Marques de Valdecilla University of Santander, ES. Prof Jose M de la Torre is member of the scientific committee of the Spanish Society of Cardiology and is fellow of the European Society of Cardiology. Former associate director of the Trans Catheter Therapeutics Meeting… View more
Joost Lumens
Job title: Full Professor of Computational Cardiology at Maastricht University
Personal History Prof Joost Lumens is a Full Professor of Computational Cardiology at Maastricht University. Academic History After completing a BSc in Biomedical Engineering, he obtained his MSc degree in Medical Engineering at the Eindhoven University of Technology (2005). He used the CircAdapt model to study the effect of ageing on left ventricular mechanics for his final MSc… View more
Job title: Interventional Cardiologist
Personal History Dr. Pilar Jiménez-Quevedo is a specialist in Interventional Cardiology based in Madrid, Spain. Academic History In 1997, Dr Jiménez-Quevedo earned her Degree in Medicine from the University of Navarra. She has a masters in Interventional Cardiology (2005) and a Doctor Cum Laude in Medicine and Surgery (2007) from the Complutense University of Madrid. From 2005 to… View more
Author(s): Michael D McGoon Added: 3 years ago
Pulmonary hypertension (PH) is a hemodynamic condition defined by pulmonary arterial systolic pressure (PASP) above an upper limit of 35mmHg, or by pulmonary arterial mean pressure (PAMP) exceeding 25mmHg at rest. Pulmonary arterial hypertension (PAH) is present when pre-capillary pulmonary vascular pressure is elevated in the absence of pulmonary capillary wedge pressure >15mmHg, such as that… View more

Prevention & Chronic Conditions
Job title: Senior Director of the cardiac care unit
ProfDiana Bonderman isSenior Director of the cardiac care unit at theMedical University of Vienna. Her clinical interests are Cardiovascular Medicine, Intensive care Medicine, Cardiovascular Medicine, Hemodynamics, Pulmonary Hypertension and Ejection Fraction. View more